Solta Medical, Inc. Updates FY 2012 Revenue Guidance To A Range In Line With Analysts' Estimates; Comments On FY 2012 EBITDA Guidance; Comments On FY 2012 Quarterly EBITDA Guidance

Solta Medical, Inc. updated outlook for fiscal 2012 and expects revenue to be in the range of $140-$143 million, Positive non-GAAP EBITDA for every quarter and for fiscal 2012. Non-GAAP EBITDA excludes non-cash amortization charges, non-cash stock based compensation charges, severance costs, and acquisition related adjustments. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $141 million and EBITDA of $15 million for fiscal 2012; EBITDA of $3.3 million for the second quarter of 2012; EBITDA of $3.4 million for the third quarter of 2012; EBITDA of $5.7 million for the fourth quarter of 2012.